XML 52 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1

Commitments and Contingencies (Details Narrative) - USD ($) $ in Thousands				3 Months Ended		5 Months Ended	9 Months Ended
	Aug. 31, 2018	Nov. 17, 2017	Nov. 07, 2017	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2018
Percentage of net profits payments to third party from sale of product		50.00%	30.00%
Credit agreement term		10 years	10 years
Total milestone payments	$ 1,104
Percentage of right to recoup				35.00%			35.00%
Payments for development				$ 1,544	$ 1,564	$ 3,067	$ 4,525
Licensor [Member]
Percentage of net profits payments to third party from sale of product				35.00%			35.00%
Licensor [Member] | Upon Execution of the Agreement [Member]
Payments for development							$ 350
Licensor [Member] | Upon FDA Acceptance [Member]
Payments for development							1,500
Licensor [Member] | Upon FDA Approval [Member]
Payments for development							1,000
Licensor [Member] | Upon Issuance of Patent Covering [Member]
Payments for development							1,500
Licensor [Member] | Product Sales [Member]
Payments for development							500
Licensor [Member] | Calendar Year [Member]
Payments for development							$ 10,000

X

- Definition

Credit agreement term.

+ References

No definition available.

+ Details

Name:	ETON_CreditAgreementTerm
Namespace Prefix:	ETON_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Total milestone payments.

+ References

No definition available.

+ Details

Name:	ETON_MilestonePayments
Namespace Prefix:	ETON_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Percentage of net profits payments to third party from sale of product.

+ References

No definition available.

+ Details

Name:	ETON_PercentageOfNetProfitsPaymentsToThirdPartyFromSaleOfProduct
Namespace Prefix:	ETON_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Percentage of right to recoup.

+ References

No definition available.

+ Details

Name:	ETON_PercentageOfRightToRecoup
Namespace Prefix:	ETON_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_TitleOfIndividualAxis=ETON_LicensorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponExecutionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponFDAAcceptanceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponFDAApprovalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_UponIssuanceOfPatentCoveringMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_ProductSalesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementScenarioAxis=ETON_CalendarYearMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: